IL161851A0 - Formulations comprising a cephalosporin compound and their use treating bacterial infections in catsand dogs - Google Patents

Formulations comprising a cephalosporin compound and their use treating bacterial infections in catsand dogs

Info

Publication number
IL161851A0
IL161851A0 IL16185102A IL16185102A IL161851A0 IL 161851 A0 IL161851 A0 IL 161851A0 IL 16185102 A IL16185102 A IL 16185102A IL 16185102 A IL16185102 A IL 16185102A IL 161851 A0 IL161851 A0 IL 161851A0
Authority
IL
Israel
Prior art keywords
catsand
dogs
formulations
bacterial infections
treating bacterial
Prior art date
Application number
IL16185102A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL161851A0 publication Critical patent/IL161851A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL16185102A 2001-11-30 2002-11-13 Formulations comprising a cephalosporin compound and their use treating bacterial infections in catsand dogs IL161851A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33853601P 2001-11-30 2001-11-30
US39893202P 2002-07-26 2002-07-26
PCT/IB2002/004743 WO2003045435A1 (en) 2001-11-30 2002-11-13 Formulations comprising a cephalosporin compound and their use treating bacterial infections in cats and dogs

Publications (1)

Publication Number Publication Date
IL161851A0 true IL161851A0 (en) 2005-11-20

Family

ID=26991236

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16185102A IL161851A0 (en) 2001-11-30 2002-11-13 Formulations comprising a cephalosporin compound and their use treating bacterial infections in catsand dogs
IL161851A IL161851A (en) 2001-11-30 2004-05-06 Formulations comprising a cephalosporin compound and their use for treating bacterial infections in cats and dogs

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161851A IL161851A (en) 2001-11-30 2004-05-06 Formulations comprising a cephalosporin compound and their use for treating bacterial infections in cats and dogs

Country Status (27)

Country Link
US (1) US7378408B2 (cg-RX-API-DMAC7.html)
EP (1) EP1448234B1 (cg-RX-API-DMAC7.html)
JP (1) JP4689959B2 (cg-RX-API-DMAC7.html)
KR (1) KR100621291B1 (cg-RX-API-DMAC7.html)
CN (1) CN100502873C (cg-RX-API-DMAC7.html)
AR (1) AR037595A1 (cg-RX-API-DMAC7.html)
AT (1) ATE406916T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002348986B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0214583B1 (cg-RX-API-DMAC7.html)
CA (1) CA2468708C (cg-RX-API-DMAC7.html)
CY (1) CY1108437T1 (cg-RX-API-DMAC7.html)
DE (1) DE60228749D1 (cg-RX-API-DMAC7.html)
DK (1) DK1448234T3 (cg-RX-API-DMAC7.html)
EA (1) EA008503B1 (cg-RX-API-DMAC7.html)
ES (1) ES2307800T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20040487A2 (cg-RX-API-DMAC7.html)
IL (2) IL161851A0 (cg-RX-API-DMAC7.html)
IS (1) IS7214A (cg-RX-API-DMAC7.html)
MA (1) MA27085A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04003724A (cg-RX-API-DMAC7.html)
NO (1) NO334818B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ532208A (cg-RX-API-DMAC7.html)
PL (1) PL212683B1 (cg-RX-API-DMAC7.html)
PT (1) PT1448234E (cg-RX-API-DMAC7.html)
TN (1) TNSN04097A1 (cg-RX-API-DMAC7.html)
TW (1) TWI248363B (cg-RX-API-DMAC7.html)
WO (1) WO2003045435A1 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021725A1 (it) 2002-08-01 2002-10-31 Zambon Spa Composizioni farmaceutiche ad attivita' antibiotica.
EP1740214B1 (en) * 2004-04-22 2007-10-03 Pfizer Products Incorporated Method of stabilizing disordered cefovecin sodium salt
EP1656930A1 (en) 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
NZ555076A (en) * 2004-12-17 2010-01-29 Venus Remedies Ltd Antibiotic combinations for providing total solution to the treatment of infections
CN101080221A (zh) * 2005-02-14 2007-11-28 维纳斯药业有限公司 抗药性细菌感染疾病的肠胃外综合治疗
ATE472996T1 (de) * 2005-10-29 2010-07-15 Intervet Int Bv Cefquinomzusammensetzungen und verfahren zu ihrer verwendung
US20080103121A1 (en) * 2006-10-30 2008-05-01 Gole Dilip J Cephalosporin derivative formulation
MX2010009628A (es) * 2008-03-04 2010-09-28 Elan Pharma Int Ltd Formulaciones liquidas estables de agentes antiinfecciosos, y regimenes de dosificacion ajustados de los agentes antiinfecciosos.
CN101352422B (zh) * 2008-09-17 2011-04-20 厦门朝阳生物工程有限公司 河豚毒素冻干粉针制剂及其制备方法
US8731841B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9050070B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9060926B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8731842B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
US8721583B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8485861B2 (en) 2008-10-31 2013-07-16 The Invention Science Fund I, Llc Systems, devices, and methods for making or administering frozen particles
US8858912B2 (en) 2008-10-31 2014-10-14 The Invention Science Fund I, Llc Frozen compositions and methods for piercing a substrate
US8793075B2 (en) 2008-10-31 2014-07-29 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9060934B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8788211B2 (en) * 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
US9072688B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9050317B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8762067B2 (en) 2008-10-31 2014-06-24 The Invention Science Fund I, Llc Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
US20100111857A1 (en) 2008-10-31 2010-05-06 Boyden Edward S Compositions and methods for surface abrasion with frozen particles
US8725420B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8545856B2 (en) 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US9060931B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US8731840B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9072799B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
ES3026983T3 (en) * 2013-03-15 2025-06-12 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
CA2991719C (en) * 2015-07-09 2023-07-04 Uniwell Laboratories Llc Pharmaceutical compositions
EP3348271B1 (en) 2015-09-07 2024-09-04 Mochida Pharmaceutical Co., Ltd. Freeze-dried alginic acid preparation
JP2020535212A (ja) 2017-09-27 2020-12-03 フェドラ・ファーマシューティカルズ・インコーポレイテッドＦｅｄｏｒａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． ジアザビシクロオクタン誘導体の結晶型及びその生産プロセス
US10584123B2 (en) 2017-09-27 2020-03-10 Fedora Pharmaceuticals Inc. Pharmaceutical forms of diazabicyclooctane derivatives and manufacturing method thereof
JP7179058B2 (ja) * 2017-09-27 2022-11-28 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 ジアザビシクロオクタン誘導体の剤形およびその生産プロセス
GB2575261B (en) 2018-07-02 2022-03-09 Norbrook Lab Ltd Intermediates in the synthesis of C3-substituted cephalosporins
CN109393004A (zh) * 2018-09-28 2019-03-01 上海锦立保鲜科技有限公司 一种利用冻品自由水升华实现真空解冻的方法
AU2022396967A1 (en) * 2021-11-26 2024-06-13 Astellas Pharma Inc. Indocyanine compound-containing solid pharmaceutical composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002748A (en) * 1976-01-19 1977-01-11 Eli Lilly And Company Method of preparing sterile essentially amorphous cefazolin for reconstitution for parenteral administration
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
JPS6045514A (ja) 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
SE8500273D0 (sv) * 1985-01-22 1985-01-22 Leo Ab Nya tricykliska foreningar, kompositioner innehallande sadana foreningar, framstellningsforfaranden och behandlingsmetoder
US5138066A (en) * 1987-08-14 1992-08-11 Hoffmann-La Roche, Inc. Intermediates for cephalosporins with sulfur-containing oxyimino side chain
KR890012960A (ko) 1988-02-05 1989-09-20 매리 앤 터커 결정성 β-락탐 용매화물
CA2024587A1 (en) * 1989-09-05 1991-03-06 Bernard Ecanow Drug delivery compositions based on biological cells or components thereof and methods
MY106399A (en) 1990-07-24 1995-05-30 Pfizer Cephalosporins and homologeus, preparation and pharmaceutical composition
US6020329A (en) * 1990-07-24 2000-02-01 Pzifer Inc. Cephaloporins and homologues, preparations and pharmaceutical compositions
US6001997A (en) * 1990-07-24 1999-12-14 Bateson; John Hargreaves Cephalosporins and homologues, preparations and pharmaceutical compositions
US5401842A (en) * 1992-09-08 1995-03-28 Bristol-Myers Squibb Company Injectable compositions of a cephalosporin dihydrate salt
EP0664117A1 (de) * 1994-01-25 1995-07-26 F. Hoffmann-La Roche Ag Liposomenlösungen
US5665760A (en) * 1995-09-18 1997-09-09 Sanofi Winthrop, Inc. Lyophilized thioxanthenone antitumor agents
KR100312622B1 (ko) * 1998-11-03 2002-02-28 김송배 생약을주성분으로한안정화된항암제조성물및그제조방법
JP2001199889A (ja) * 1999-11-11 2001-07-24 Takeda Chem Ind Ltd 縮合ピリダジン誘導体を含有してなる点鼻用剤
WO2001039836A1 (en) 1999-12-01 2001-06-07 Natco Pharma Limited A rapid acting freeze dired oral pharmaceutical composition for treating migraine
GB0002835D0 (en) * 2000-02-09 2000-03-29 Melvin William T Drug resistance in cancer
GB0019124D0 (en) 2000-08-03 2000-09-27 Pfizer Novel process
CZ20031525A3 (cs) * 2000-12-04 2004-04-14 Pfizer Products Inc. Způsob přípravy 3-cyklickým etherem substituovaného cefalosporinu a meziprodukty pro tuto přípravu

Also Published As

Publication number Publication date
AU2002348986B2 (en) 2008-04-03
TW200300351A (en) 2003-06-01
TNSN04097A1 (fr) 2006-06-01
DK1448234T3 (da) 2008-11-03
PT1448234E (pt) 2008-10-02
IS7214A (is) 2004-04-07
JP2005511642A (ja) 2005-04-28
ATE406916T1 (de) 2008-09-15
JP4689959B2 (ja) 2011-06-01
EP1448234B1 (en) 2008-09-03
HRP20040487A2 (en) 2004-10-31
US7378408B2 (en) 2008-05-27
NO334818B1 (no) 2014-06-02
CA2468708A1 (en) 2003-06-05
TWI248363B (en) 2006-02-01
AU2002348986A1 (en) 2003-06-10
NZ532208A (en) 2007-01-26
CA2468708C (en) 2008-08-19
EA200400489A1 (ru) 2004-10-28
PL370083A1 (en) 2005-05-16
HK1071292A1 (zh) 2005-07-15
IL161851A (en) 2011-11-30
DE60228749D1 (de) 2008-10-16
BR0214583A (pt) 2004-11-03
EA008503B1 (ru) 2007-06-29
ES2307800T3 (es) 2008-12-01
KR20040058345A (ko) 2004-07-03
PL212683B1 (pl) 2012-11-30
CN100502873C (zh) 2009-06-24
US20030186957A1 (en) 2003-10-02
CY1108437T1 (el) 2014-04-09
WO2003045435A1 (en) 2003-06-05
CN1604793A (zh) 2005-04-06
NO20042271L (no) 2004-07-22
MA27085A1 (fr) 2004-12-20
MXPA04003724A (es) 2005-04-08
EP1448234A1 (en) 2004-08-25
AR037595A1 (es) 2004-11-17
KR100621291B1 (ko) 2006-09-13
BRPI0214583B1 (pt) 2015-11-17

Similar Documents

Publication Publication Date Title
IL161851A0 (en) Formulations comprising a cephalosporin compound and their use treating bacterial infections in catsand dogs
AU2001286878A1 (en) Oxazolidinones and their use as antibacterial agents
AU2001268564A1 (en) Alpha-glycosylceramides for treating bacterial and fungal infections
AU2001272935A1 (en) Cobalamin compounds useful as antibiotic agents and as imaging agents
SI1427711T1 (sl) Oksazolidinonski in/ali izoksazolinski derivati kot antibakterijska sredstva
AU2002218365A1 (en) Heterocyclylalkyl piperidine derivatives and their use as antimicrobial agents
AU2002346388A1 (en) Absorbent component and use as pet litter
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2003292422A1 (en) Oxazolidinone derivatives and their use as antibacterial agents
AU2001276149A1 (en) Cleaning and disinfecting agent
AU2001275736A1 (en) Improvements in animal cages
PL361836A1 (en) Prevention of hoof infections in stockbreeding
EP1511753A4 (en) ANTIMICROBIAL MEDIUM AND ITS USE
AU5464901A (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
GB0007530D0 (en) Trityl-type compounds and their use
GB0021497D0 (en) Compounds and their use
AU2001251370A1 (en) Antimicrobial methods and materials
GB0018887D0 (en) Compound and their therapeutic use
IL162103A0 (en) Methods of treating bacterial infections in dogs and cats
AU2001267565A1 (en) Anthelminthic agents for the prevention of parasitic infections in humans and animals II
AU3002901A (en) Bacterial galactanases and use thereof
AU2002211637A1 (en) Probiotic compositions and methods against bacterial infection in livestock animals
AU2535600A (en) Bacterial galactanases and use thereof
AU2003267962A8 (en) Antibacterial compounds and methods for treating gram positive bacterial infections
AU2003209241A1 (en) Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections